1. Home
  2. SDHC vs EVO Comparison

SDHC vs EVO Comparison

Compare SDHC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith Douglas Homes Corp.

SDHC

Smith Douglas Homes Corp.

HOLD

Current Price

$10.83

Market Cap

102.3M

Sector

N/A

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.76

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDHC
EVO
Founded
2008
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
102.3M
934.1M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
SDHC
EVO
Price
$10.83
$2.76
Analyst Decision
Hold
Strong Buy
Analyst Count
6
1
Target Price
$14.60
$7.00
AVG Volume (30 Days)
77.5K
91.4K
Earning Date
04-29-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.06
N/A
Revenue
$971,116,000.00
N/A
Revenue This Year
$4.21
$1.37
Revenue Next Year
$11.07
$10.05
P/E Ratio
$181.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.81
$2.31
52 Week High
$23.50
$4.80

Technical Indicators

Market Signals
Indicator
SDHC
EVO
Relative Strength Index (RSI) 34.35 42.25
Support Level $11.18 $2.63
Resistance Level $15.45 $3.36
Average True Range (ATR) 0.68 0.08
MACD -0.20 -0.05
Stochastic Oscillator 13.91 22.16

Price Performance

Historical Comparison
SDHC
EVO

About SDHC Smith Douglas Homes Corp.

Smith Douglas Homes Corpis a builder of single-family homes in communities in certain markets in the southeastern and southern United States. The Company's homes and communities are targeted to first-time and empty-nest homebuyers. The Company currently operates in metropolitan Atlanta, Birmingham, Chattanooga, Central Georgia, Charlotte, Dallas-Fort Worth, Greenville, Alabama Gulf Coast, Huntsville, Nashville, Raleigh and Houston. Its operations are currently organized into ten geographical divisions which comprise two reportable segments. Its Southeast segment consists of its Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of its Alabama, Dallas-Fort Worth, Houston, Nashville, and Alabama Gulf Coast divisions.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: